Scioderm, Inc. was acquired by Amicus Therapeutics, Inc. in September of 2015. Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare genetic diseases.
Amicus, together with Scioderm, was developing an investigational topical treatment (SD-101) for people with Epidermolysis Bullosa (EB), which is a rare genetic connective tissue disorder. In September of 2017, results of a Phase 3 clinical study to assess the efficacy and safety of SD-101, showed that it did not show a statistically significant difference from placebo. Subsequently, Amicus discontinued the program, but shared the clinical data and additional information related to the EB program with key stakeholders including other companies with investigational treatments for EB as well as the broader EB community.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 4601 Creekstone Drive, Suite 160,united States
- Phone
- 919-274-0703
- in****@****erm.com
- Industry
- Biotechnology
- Website
- sderm.com
- Keywords
- Epidermolysis Bullosa (EB).
- HQ
- Durham, NC
Scioderm, Inc., An Amicus Therapeutics Company Questions
Scioderm, Inc., An Amicus Therapeutics Company's helpline number is 919-274-0703
Scioderm, Inc., An Amicus Therapeutics Company's website is sderm.com
Scioderm, Inc., An Amicus Therapeutics Company's LinkedIn profile is https://www.linkedin.com/company/scioderm-inc-
Scioderm, Inc., An Amicus Therapeutics Company has
2 employees.
View email and phone details for 2
employees at Scioderm, Inc., An Amicus Therapeutics Company.
Scioderm, Inc., An Amicus Therapeutics Company's industry is
Biotechnology
Scioderm, Inc., An Amicus Therapeutics Company's top competitors are
Ptc Therapeutics, Inc.,
Amicus Therapeutics,
Vivus Llc,
Spectrum Pharmaceuticals, Inc.,
Biotechnology Innovation Organization,
Acorda Therapeutics, Inc.,
Alnylam Pharmaceuticals,
Ultragenyx,
Seagen,
Sarepta Therapeutics.
Scioderm, Inc., An Amicus Therapeutics Company's support email address is info@sdrerm.com
Scioderm, Inc., An Amicus Therapeutics Company's categories are Biotechnology
Scioderm, Inc., An Amicus Therapeutics Company's founding year is 2012
